Alignment Healthcare, Inc. (ALHC) — Analyst outlook / Analyst consensus target is. Based on 16 analyst ratings, the consensus is bullish — 1 Strong Buy, 13 Buy, 2 Hold.
The consensus price target is $24.50 (low: $18.00, high: $30.00), representing an upside of 15.1% from the current price $21.28.
Analysts estimate Earnings Per Share (EPS) of $-0.68 and revenue of $2.68B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-0.67 vs est $-0.68 (beat +1.9%). 2025: actual $0.00 vs est $-0.10 (beat +96.4%). Analyst accuracy: 0%.
ALHC Stock — 12-Month Price Forecast
$24.50
▲ +15.13% Upside
Average Price Target
Based on 16 Wall Street analysts offering 12-month price targets for Alignment Healthcare, Inc., the average price target is $24.50, with a high forecast of $30.00, and a low forecast of $18.00.
The average price target represents a +15.13% change from the last price of $21.28.
Highest Price Target
$30.00
Average Price Target
$24.50
Lowest Price Target
$18.00
ALHC Analyst Ratings
Buy
Based on 16 analysts giving stock ratings to Alignment Healthcare, Inc. in the past 3 months
EPS Estimates — ALHC
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$0.67
vs Est –$0.68
▲ 1.9% off
2025
Actual –$0.00
vs Est –$0.10
▲ 2,660.0% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
Revenue Estimates — ALHC
99%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $2.704B
vs Est $2.679B
▲ 0.9% off
2025
Actual $3.949B
vs Est $3.939B
▲ 0.2% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
